Deep Track Capital’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
Deep Track Capital's DSGN Position: Q3 2026 in Review
Deep Track Capital opened a new position in Design Therapeutics (DSGN) in Q3 2026: 1,323,986 shares worth $16.6M. The stake represents 0.27% of the portfolio and ranks #58 among its holdings.
96 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.
- Deep Track Capital held 1,323,986 shares of Design Therapeutics worth $16.6M as of Q3 2026.
- Design Therapeutics was a new Deep Track Capital position in Q3 2026.
- Design Therapeutics made up 0.27% of Deep Track Capital's portfolio in Q3 2026, its #58 holding.
- 96 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.
Based on Deep Track Capital's 13F filing for Q3 2026, filed 16 Nov 2026.